Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment

Published:2023-02-21 Issue:4 Volume:18 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Da Fonseca Leonardo¹,Uratani Lucas¹,Soares Gabriella¹,Do Amaral Paulo¹,De Souza Melo Alencar Regiane²,Chagas Aline²,Alves Venancio²,Carrilho Flair²

Affiliation:

1. Department of Oncology, ICESP - Institute of Cancer of Sao Paulo, University of Sao Paulo School of Medicine, 01246‑000 Sao Paulo‑SP, Brazil

2. Sao Paulo Clínicas Liver Cancer Group, University of São Paulo School of Medicine, 01246‑000 Sao Paulo‑SP, Brazil

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference34 articles.

1. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update;Reig;J Hepatol,2022

2. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

3. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

4. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial;Kudo;Lancet,2018

5. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): A randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening of Candidate Inflammatory Markers of Epithelial Cells in Hepatocellular Carcinoma Based on Integration Analysis of TCGA/ICGC Databases and Single-cell Sequencing;Recent Patents on Anti-Cancer Drug Discovery;2024-01-30

2. Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics;Journal of Hepatocellular Carcinoma;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3